197 related articles for article (PubMed ID: 31027375)
21. Hypoxia and HIF-1 Trigger Marek's Disease Virus Reactivation in Lymphoma-Derived Latently Infected T Lymphocytes.
Mallet C; Cochard J; Leclercq S; Trapp-Fragnet L; Chouteau P; Denesvre C
J Virol; 2022 Mar; 96(5):e0142721. PubMed ID: 34936483
[TBL] [Abstract][Full Text] [Related]
22. Real-time PCR for differential quantification of CVI988 vaccine virus and virulent strains of Marek's disease virus.
Baigent SJ; Nair VK; Le Galludec H
J Virol Methods; 2016 Jul; 233():23-36. PubMed ID: 26973285
[TBL] [Abstract][Full Text] [Related]
23. Infection of macrophages by a lymphotropic herpesvirus: a new tropism for Marek's disease virus.
Barrow AD; Burgess SC; Baigent SJ; Howes K; Nair VK
J Gen Virol; 2003 Oct; 84(Pt 10):2635-2645. PubMed ID: 13679597
[TBL] [Abstract][Full Text] [Related]
24. Latency and tumorigenesis in Marek's disease.
Nair V
Avian Dis; 2013 Jun; 57(2 Suppl):360-5. PubMed ID: 23901747
[TBL] [Abstract][Full Text] [Related]
25. Syngeneic lysis of reticuloendotheliosis virus-transformed cell lines transfected with Marek's disease virus genes by virus-specific cytotoxic T cells.
Uni Z; Pratt WD; Miller MM; O'Connell PH; Schat KA
Vet Immunol Immunopathol; 1994 Dec; 44(1):57-69. PubMed ID: 7725630
[TBL] [Abstract][Full Text] [Related]
26. Genetic interference exerted by Salmonella-delivered CRISPR/Cas9 significantly reduces the pathological burden caused by Marek's disease virus in chickens.
Senevirathne A; Hewawaduge C; Lee JH
Vet Res; 2021 Sep; 52(1):125. PubMed ID: 34593043
[TBL] [Abstract][Full Text] [Related]
27. Syngeneic Marek's disease virus (MDV)-specific cell-mediated immune responses against immediate early, late, and unique MDV proteins.
Omar AR; Schat KA
Virology; 1996 Aug; 222(1):87-99. PubMed ID: 8806490
[TBL] [Abstract][Full Text] [Related]
28. Efficient Mutagenesis of Marek's Disease Virus-Encoded microRNAs Using a CRISPR/Cas9-Based Gene Editing System.
Luo J; Teng M; Zai X; Tang N; Zhang Y; Mandviwala A; Reddy VRAP; Baigent S; Yao Y; Nair V
Viruses; 2020 Apr; 12(4):. PubMed ID: 32325942
[TBL] [Abstract][Full Text] [Related]
29. Marek's Disease Virus Telomeric Integration Profiles of Neoplastic Host Tissues Reveal Unbiased Chromosomal Selection and Loss of Cellular Diversity during Tumorigenesis.
Glass MC; Smith JM; Cheng HH; Delany ME
Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34681024
[TBL] [Abstract][Full Text] [Related]
30. Recombinant Marek's disease virus (MDV)-derived lymphoblastoid cell lines: regulation of a marker gene within the context of the MDV genome.
Parcells MS; Dienglewicz RL; Anderson AS; Morgan RW
J Virol; 1999 Feb; 73(2):1362-73. PubMed ID: 9882341
[TBL] [Abstract][Full Text] [Related]
31. Expression of Marek's disease virus phosphorylated polypeptide pp38 produces splice variants and enhances metabolic activity.
Li X; Jarosinski KW; Schat KA
Vet Microbiol; 2006 Oct; 117(2-4):154-68. PubMed ID: 16876339
[TBL] [Abstract][Full Text] [Related]
32. Expression of Marek's disease virus (MDV) serotype 2 gene which has partial homology with MDV serotype 1 pp38 gene.
Ono M; Maeda K; Kawaguchi Y; Jang HK; Tohya Y; Niikura M; Mikami T
Virus Res; 1995 Feb; 35(2):223-9. PubMed ID: 7762295
[TBL] [Abstract][Full Text] [Related]
33. Induction of DNA Damages upon Marek's Disease Virus Infection: Implication in Viral Replication and Pathogenesis.
Bencherit D; Remy S; Le Vern Y; Vychodil T; Bertzbach LD; Kaufer BB; Denesvre C; Trapp-Fragnet L
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978699
[TBL] [Abstract][Full Text] [Related]
34. Protection against Marek's disease by a fowlpox virus recombinant expressing the glycoprotein B of Marek's disease virus.
Nazerian K; Lee LF; Yanagida N; Ogawa R
J Virol; 1992 Mar; 66(3):1409-13. PubMed ID: 1310755
[TBL] [Abstract][Full Text] [Related]
35. Nucleotide sequence analysis of Marek's disease virus (MDV) serotype 2 homolog of MDV serotype 1 pp38, an antigen associated with transformed cells.
Ono M; Kawaguchi Y; Maeda K; Kamiya N; Tohya Y; Kai C; Niikura M; Mikami T
Virology; 1994 May; 201(1):142-6. PubMed ID: 8178479
[TBL] [Abstract][Full Text] [Related]
36. Comparative analysis of oncogenic genes revealed unique evolutionary features of field Marek's disease virus prevalent in recent years in China.
Tian M; Zhao Y; Lin Y; Zou N; Liu C; Liu P; Cao S; Wen X; Huang Y
Virol J; 2011 Mar; 8():121. PubMed ID: 21406076
[TBL] [Abstract][Full Text] [Related]
37. Interferon-containing supernatants increase Marek's disease herpesvirus genomes and gene transcription levels, but not virion replication in vitro.
Levy AM; Burgess SC; Davidson I; Underwood G; Leitner G; Heller ED
Viral Immunol; 2003; 16(4):501-9. PubMed ID: 14733737
[TBL] [Abstract][Full Text] [Related]
38. Structural analysis and transcriptional mapping of the Marek's disease virus gene encoding pp38, an antigen associated with transformed cells.
Cui ZZ; Lee LF; Liu JL; Kung HJ
J Virol; 1991 Dec; 65(12):6509-15. PubMed ID: 1658357
[TBL] [Abstract][Full Text] [Related]
39. Alterations of the MDV oncogenic regions in an MDV transformed lymphoblastoid cell line.
Le Rouzic E; Thoraval P; Afanassieff M; Cherel Y; Dambrine G; Perbal B
Mol Pathol; 2002 Aug; 55(4):262-72. PubMed ID: 12147717
[TBL] [Abstract][Full Text] [Related]
40. The Marek's Disease Virus Unique Gene MDV082 Is Dispensable for Virus Replication but Contributes to a Rapid Disease Onset.
You Y; Conradie AM; Kheimar A; Bertzbach LD; Kaufer BB
J Virol; 2021 Jul; 95(15):e0013121. PubMed ID: 34011541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
